Matches in Wikidata for { <http://www.wikidata.org/entity/Q96138056> ?p ?o ?g. }
- Q96138056 description "2020 nî lūn-bûn" @default.
- Q96138056 description "2020年の論文" @default.
- Q96138056 description "2020年学术文章" @default.
- Q96138056 description "2020年学术文章" @default.
- Q96138056 description "2020年学术文章" @default.
- Q96138056 description "2020年学术文章" @default.
- Q96138056 description "2020年学术文章" @default.
- Q96138056 description "2020年學術文章" @default.
- Q96138056 description "2020年學術文章" @default.
- Q96138056 description "2020年學術文章" @default.
- Q96138056 description "2020年學術文章" @default.
- Q96138056 description "2020年學術文章" @default.
- Q96138056 description "2020年學術文章" @default.
- Q96138056 description "2020년 논문" @default.
- Q96138056 description "article científic" @default.
- Q96138056 description "article scientific" @default.
- Q96138056 description "article scientifique publié en 2020" @default.
- Q96138056 description "articol științific" @default.
- Q96138056 description "articolo scientifico" @default.
- Q96138056 description "artigo científico (publicado na 2020)" @default.
- Q96138056 description "artigo científico (publicado na 2020)" @default.
- Q96138056 description "artigo científico" @default.
- Q96138056 description "artikull shkencor" @default.
- Q96138056 description "artikulong pang-agham" @default.
- Q96138056 description "artykuł naukowy opublikowany 15 maja 2020" @default.
- Q96138056 description "artículo científico publicado en 2020" @default.
- Q96138056 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q96138056 description "bilimsel makale" @default.
- Q96138056 description "bài báo khoa học" @default.
- Q96138056 description "mokslinis straipsnis" @default.
- Q96138056 description "naučni članak" @default.
- Q96138056 description "scienca artikolo" @default.
- Q96138056 description "scientific article published on 15 May 2020" @default.
- Q96138056 description "teaduslik artikkel" @default.
- Q96138056 description "tieteellinen artikkeli" @default.
- Q96138056 description "tudományos cikk" @default.
- Q96138056 description "vedecký článok" @default.
- Q96138056 description "vetenskaplig artikel" @default.
- Q96138056 description "videnskabelig artikel (udgivet 2020)" @default.
- Q96138056 description "vitenskapelig artikkel" @default.
- Q96138056 description "vitskapeleg artikkel" @default.
- Q96138056 description "vědecký článek" @default.
- Q96138056 description "wetenschappelijk artikel" @default.
- Q96138056 description "wissenschaftlicher Artikel" @default.
- Q96138056 description "επιστημονικό άρθρο" @default.
- Q96138056 description "мақолаи илмӣ" @default.
- Q96138056 description "мақолаи илмӣ" @default.
- Q96138056 description "наукова стаття, опублікована 15 травня 2020" @default.
- Q96138056 description "научна статия" @default.
- Q96138056 description "научная статья" @default.
- Q96138056 description "научни чланак" @default.
- Q96138056 description "научни чланак" @default.
- Q96138056 description "գիտական հոդված" @default.
- Q96138056 description "מאמר מדעי" @default.
- Q96138056 description "سائنسی مضمون" @default.
- Q96138056 description "مقالة علمية" @default.
- Q96138056 description "مقالهٔ علمی" @default.
- Q96138056 description "২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q96138056 description "บทความทางวิทยาศาสตร์" @default.
- Q96138056 description "სამეცნიერო სტატია" @default.
- Q96138056 name "Brentuximab vedotin for refractory anaplastic lymphoma kinase-negative anaplastic large cell lymphoma in leukemic phase with RUNX3 overexpression" @default.
- Q96138056 name "Brentuximab vedotin for refractory anaplastic lymphoma kinase-negative anaplastic large cell lymphoma in leukemic phase with RUNX3 overexpression" @default.
- Q96138056 type Item @default.
- Q96138056 label "Brentuximab vedotin for refractory anaplastic lymphoma kinase-negative anaplastic large cell lymphoma in leukemic phase with RUNX3 overexpression" @default.
- Q96138056 label "Brentuximab vedotin for refractory anaplastic lymphoma kinase-negative anaplastic large cell lymphoma in leukemic phase with RUNX3 overexpression" @default.
- Q96138056 prefLabel "Brentuximab vedotin for refractory anaplastic lymphoma kinase-negative anaplastic large cell lymphoma in leukemic phase with RUNX3 overexpression" @default.
- Q96138056 prefLabel "Brentuximab vedotin for refractory anaplastic lymphoma kinase-negative anaplastic large cell lymphoma in leukemic phase with RUNX3 overexpression" @default.
- Q96138056 P1433 Q96138056-BE00E747-7578-4823-A54A-6CBB776B1538 @default.
- Q96138056 P1476 Q96138056-9E997243-A90F-47EA-B5DF-83C3E4807DD2 @default.
- Q96138056 P2093 Q96138056-036B2734-ADD5-44DD-BA05-5F107E893DEE @default.
- Q96138056 P2093 Q96138056-07FC1F09-F401-43F7-A420-C81F87AA3BF3 @default.
- Q96138056 P2093 Q96138056-2B0C856E-8169-4409-9C8A-030A27177A15 @default.
- Q96138056 P2093 Q96138056-6622EB46-F04B-4CB3-8526-8731209B4E26 @default.
- Q96138056 P2093 Q96138056-791658B3-7FB3-4CDB-99C9-C812F02FB3F9 @default.
- Q96138056 P2093 Q96138056-95940140-59FA-40FB-8785-56928E059C68 @default.
- Q96138056 P2093 Q96138056-970C45A8-BEB6-4656-9857-C18D04EE0631 @default.
- Q96138056 P2093 Q96138056-AA04A634-F5D4-4D72-8A37-97BED9F902C8 @default.
- Q96138056 P2093 Q96138056-C8987AAE-3D14-4E4B-A1E0-EBFDC29172A0 @default.
- Q96138056 P2093 Q96138056-D1492AD5-9787-48A3-B731-67A2C173D755 @default.
- Q96138056 P2093 Q96138056-DFDF54D8-7C2B-4ACD-B703-A05368ED7933 @default.
- Q96138056 P2093 Q96138056-EE0F3A1D-C42C-41EF-9C0A-7895F27E5788 @default.
- Q96138056 P275 Q96138056-fa997894-cdf2-4762-9688-92dc0d8b5d4d @default.
- Q96138056 P304 Q96138056-33DB6623-A1EB-4615-A5CA-3FE25EFB7CCF @default.
- Q96138056 P31 Q96138056-0A8C5412-7CD0-40F4-BF38-88B97CB77812 @default.
- Q96138056 P356 Q96138056-F3FE9FD7-428D-41E0-8E86-122EE1A8DB83 @default.
- Q96138056 P433 Q96138056-E92653F7-07BD-4194-8B0E-CDF36F641837 @default.
- Q96138056 P478 Q96138056-79065DAD-3DD0-4112-A994-CAE321756549 @default.
- Q96138056 P577 Q96138056-0A9FA97E-98FB-43EA-A548-EC0E67AF0CFF @default.
- Q96138056 P6216 Q96138056-27279a48-3a29-464f-8cfd-e761480b0abd @default.
- Q96138056 P698 Q96138056-2324CCCE-F3C4-44C4-BDF0-5493B1F10CE0 @default.
- Q96138056 P932 Q96138056-EE1EACCF-9A09-44D2-89A8-BDA17F22476E @default.
- Q96138056 P356 HR.2020.8368 @default.
- Q96138056 P698 32499905 @default.
- Q96138056 P1433 Q26841985 @default.
- Q96138056 P1476 "Brentuximab vedotin for refractory anaplastic lymphoma kinase-negative anaplastic large cell lymphoma in leukemic phase with RUNX3 overexpression" @default.
- Q96138056 P2093 "Akinori Nishikawa" @default.
- Q96138056 P2093 "Hideki Kosako" @default.
- Q96138056 P2093 "Kenji Warigaya" @default.
- Q96138056 P2093 "Masakazu Fujimoto" @default.
- Q96138056 P2093 "Shin-Ichi Murata" @default.